牛叉诊股

[{"date":"2026.05.19","stock":"1.30","trade":"0.64","ind":"0.92"},{"date":"2026.05.18","stock":"-1.32","trade":"-1.49","ind":"-0.09"},{"date":"2026.05.15","stock":"-3.48","trade":"-0.71","ind":"-1.02"},{"date":"2026.05.14","stock":"-6.02","trade":"-1.71","ind":"-1.52"},{"date":"2026.05.13","stock":"3.68","trade":"-0.44","ind":"0.67"},{"date":"2026.05.12","stock":"-5.79","trade":"-1.41","ind":"-0.25"},{"date":"2026.05.11","stock":"-10.00","trade":"1.65","ind":"1.08"},{"date":"2026.05.08","stock":"3.33","trade":"0.14","ind":"-0.00"},{"date":"2026.05.07","stock":"-10.00","trade":"-0.07","ind":"0.48"},{"date":"2026.05.06","stock":"9.67","trade":"0.78","ind":"1.17"},{"date":"2026.04.30","stock":"-4.35","trade":"0.52","ind":"0.11"},{"date":"2026.04.29","stock":"8.62","trade":"0.65","ind":"0.71"},{"date":"2026.04.28","stock":"6.60","trade":"-0.61","ind":"-0.19"},{"date":"2026.04.27","stock":"-2.05","trade":"0.54","ind":"0.16"},{"date":"2026.04.24","stock":"3.65","trade":"-0.33","ind":"-0.33"},{"date":"2026.04.23","stock":"10.00","trade":"-1.30","ind":"-0.32"},{"date":"2026.04.22","stock":"-3.86","trade":"0.43","ind":"0.52"},{"date":"2026.04.21","stock":"2.18","trade":"-0.98","ind":"0.07"},{"date":"2026.04.20","stock":"-2.08","trade":"-0.37","ind":"0.76"},{"date":"2026.04.17","stock":"-6.25","trade":"-1.46","ind":"-0.10"},{"date":"2026.04.16","stock":"0.90","trade":"-0.14","ind":"0.70"}]

美诺华,上证指数,化学制药指数

压力支撑

该股压力位为50.42元，支撑位为48.75元。

[{"text":"\u538b\u529b\u4f4d","value":"50.42","date":1779120000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"48.75","date":1779120000,"color":"0x0b52a1"}]

多空趋势

多头行情中，目前处于回落整理阶段且下跌有加速趋势。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：4.4资金面打败了67%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，主力持仓比10日前减少，已没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

化学制药行业，近5日资金流出较多，不建议投资者关注该行业的个股。

更新时间：05月20日 08:08

机构今日流向(万元)	-2345.99	机构5日流向(万元)	-11322.87
机构10日流向(万元)	-16109.97	机构20日流向(万元)	-30921.29

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量减少364.47万股，其中基金净减仓6家，主力净增仓18家，暂未发现中长期投资价值。

截止2025-12-31，共50家主力机构（基金48家，一般法人2家），持仓量总计4753.2万股，占流通A股21.99%
其中，基金持仓与2025-06-30相比：
增仓：1家，增持 0.50万股
减仓：7家，减持 57.74万股
新出现在主力名单中：39家，持有154.41万股
从主力名单中消失：21家，原持有461.64万股

消息面诊股

诊断结果：7.4消息面打败了99%的股票今日有利好新闻的公司

近期该股利好消息较多，投资者可加强关注。

消息面得分最高的股票

消息列表

一般消息	股东大会	年度股东大会	2026-04-25
利好	分红转增	10转4.0股派1.550元(含税...	2026-04-25
重大利好	业绩预告	业绩大幅上升	2026-01-27
一般消息	重大事项	关联交易	2026-01-17
一般消息	高管变动	取消监事会	2025-09-11
一般消息	分红转增	不分配不转增	2025-08-27

一年消息统计

	所有消息	重大消息	非重大消息
利好	2条	1条	1条
利空	0条	0条	0条

行业面诊股

诊断结果：1.8行业面打败了17%的股票化学制药行业最新资金流向

近10日来该行业走势不明显，明显跑输大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，明显跑输大盘。

[{"date":"2026.05.19","price":"0.92","value":"0.64"},{"date":"2026.05.18","price":"-0.09","value":"-1.49"},{"date":"2026.05.15","price":"-1.02","value":"-0.71"},{"date":"2026.05.14","price":"-1.52","value":"-1.71"},{"date":"2026.05.13","price":"0.67","value":"-0.44"},{"date":"2026.05.12","price":"-0.25","value":"-1.41"},{"date":"2026.05.11","price":"1.08","value":"1.65"},{"date":"2026.05.08","price":"-0.00","value":"0.14"},{"date":"2026.05.07","price":"0.48","value":"-0.07"},{"date":"2026.05.06","price":"1.17","value":"0.78"},{"date":"2026.04.30","price":"0.11","value":"0.52"},{"date":"2026.04.29","price":"0.71","value":"0.65"},{"date":"2026.04.28","price":"-0.19","value":"-0.61"},{"date":"2026.04.27","price":"0.16","value":"0.54"},{"date":"2026.04.24","price":"-0.33","value":"-0.33"},{"date":"2026.04.23","price":"-0.32","value":"-1.30"},{"date":"2026.04.22","price":"0.52","value":"0.43"},{"date":"2026.04.21","price":"0.07","value":"-0.98"},{"date":"2026.04.20","price":"0.76","value":"-0.37"},{"date":"2026.04.17","price":"-0.10","value":"-1.46"},{"date":"2026.04.16","price":"0.70","value":"-0.14"}]

上证指数,化学制药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	南新制药	31.31%	-3.24%	5.3分
2	宏源药业	29.92%	-1.86%	5.9分
3	德展健康	27.03%	14.70%	5.8分
4	多瑞医药	26.13%	10.66%	5.1分
5	昂利康	22.30%	31.46%	5.5分
6	共同药业	20.67%	-3.61%	5.3分
7	司太立	18.29%	10.34%	5.7分
8	仟源医药	15.07%	-2.65%	5.9分
9	纳微科技	14.66%	3.19%	6.5分
10	溢多利	14.55%	-1.35%	5.8分
11	翰宇药业	14.18%	18.89%	6.5分
12	前沿生物	8.58%	-9.43%	5.8分
13	上海谊众	8.12%	-4.61%	5.8分
14	尔康制药	8.07%	-8.68%	5.1分
15	ST天圣	8.06%	0.55%	5.3分
16	贝达药业	8.03%	-7.92%	4.2分
17	广生堂	7.79%	8.96%	5.1分
18	东亚药业	7.74%	3.58%	6.3分
19	金石亚药	6.55%	-2.69%	4.8分
20	河化股份	5.24%	1.74%	5.6分
21	广济药业	5.14%	-1.60%	5.2分
22	博瑞医药	4.71%	-6.36%	4.4分
23	赛托生物	4.35%	-3.50%	5.6分
24	ST景峰	3.93%	-0.94%	5.5分
25	一品红	3.86%	-8.34%	3.7分
26	ST复华	2.82%	-0.63%	5.2分
27	ST诺泰	2.31%	-3.80%	5.5分
28	西点药业	2.13%	-2.25%	4.7分
29	通化金马	1.70%	0.73%	4.5分
30	奥翔药业	1.66%	2.46%	5.5分
31	本立科技	1.29%	-1.59%	4.5分
32	威尔药业	1.24%	-3.69%	5.8分
33	-	0.75%	-4.13%	分
34	华海药业	0.68%	-4.04%	4.8分
35	汇宇制药	0.60%	-1.72%	5.2分
36	首药控股	0.40%	-1.65%	5.0分
37	-	0.40%	-3.61%	分
38	-	0.29%	-4.02%	分
39	鲁抗医药	-0.48%	-2.00%	5.2分
40	奥赛康	-0.62%	-6.60%	4.3分
41	-	-0.75%	-2.46%	分
42	-	-0.99%	-3.58%	分
43	民生健康	-1.39%	-3.99%	4.7分
44	兴齐眼药	-1.64%	-1.43%	4.2分
45	三圣股份	-1.72%	-5.00%	4.3分
46	泽璟制药	-2.15%	-11.03%	4.3分
47	科源制药	-2.16%	-9.81%	5.2分
48	哈三联	-2.34%	-2.42%	4.7分
49	康芝药业	-2.35%	-1.19%	4.9分
50	华纳药厂	-2.36%	-7.72%	4.5分
51	复旦张江	-2.49%	-2.12%	4.3分
52	宣泰医药	-2.63%	-2.32%	4.7分
53	新华制药	-2.64%	-2.64%	5.2分
54	花园生物	-3.24%	-5.44%	4.8分
55	仙琚制药	-3.54%	-1.13%	5.3分
56	金城医药	-3.95%	-4.80%	5.0分
57	悦康药业	-4.06%	-10.51%	4.7分
58	莎普爱思	-4.15%	-1.22%	4.0分
59	拓新药业	-4.23%	-8.82%	3.3分
60	-	-4.29%	-6.78%	分
61	-	-4.37%	-6.12%	分
62	圣诺生物	-4.52%	-4.65%	4.2分
63	津药药业	-4.61%	-17.36%	6.0分
64	润都股份	-4.73%	-3.68%	4.6分
65	向日葵	-4.93%	-4.69%	4.5分
66	-	-5.15%	-1.38%	分
67	ST惠程	-5.24%	-2.69%	4.3分
68	ST人福	-5.32%	-2.55%	4.3分
69	海欣股份	-5.47%	-4.22%	4.3分
70	汉商集团	-5.51%	-1.75%	4.6分
71	卫信康	-5.51%	-4.42%	4.8分
72	海正药业	-5.55%	-4.97%	4.3分
73	灵康药业	-5.59%	-1.79%	4.8分
74	福安药业	-5.65%	-2.20%	4.4分
75	天新药业	-5.85%	-1.82%	4.7分
76	-	-6.12%	-4.96%	分
77	莱美药业	-6.56%	-7.29%	3.7分
78	川宁生物	-6.58%	-3.88%	4.5分
79	百济神州	-6.62%	-10.45%	5.7分
80	泰恩康	-6.69%	-1.42%	4.0分
81	华润双鹤	-6.82%	-3.34%	4.6分
82	富士莱	-7.11%	-1.11%	4.9分
83	赛分科技	-7.19%	-0.76%	5.8分
84	国药现代	-7.26%	-3.66%	4.6分
85	国邦医药	-7.30%	-3.31%	4.6分
86	诚意药业	-7.44%	-5.11%	4.6分
87	浙江医药	-7.70%	-1.53%	4.3分
88	微芯生物	-7.82%	-6.64%	4.4分
89	海创药业	-7.90%	-4.51%	4.7分
90	健康元	-7.92%	-5.74%	4.2分
91	普洛药业	-7.97%	-11.26%	4.3分
92	海普瑞	-8.37%	-1.89%	4.3分
93	海思科	-8.57%	-5.84%	5.0分
94	常山药业	-8.58%	-7.28%	3.9分
95	新天地	-8.62%	-1.27%	3.7分
96	华邦健康	-8.75%	-2.04%	4.6分
97	科伦药业	-8.77%	-3.46%	4.0分
98	永安药业	-9.01%	-6.70%	4.3分
99	艾力斯	-9.05%	-4.93%	5.0分
100	丰原药业	-9.10%	-2.67%	4.6分
101	小方制药	-9.10%	-3.58%	4.4分
102	丽珠集团	-9.12%	-2.81%	4.3分
103	美诺华	-9.32%	-5.98%	4.4分
104	凯因科技	-9.37%	-2.56%	4.3分
105	亨迪药业	-9.40%	-4.48%	4.0分
106	复星医药	-9.40%	-4.46%	4.3分
107	辰欣药业	-9.42%	-4.70%	4.2分
108	罗欣药业	-9.48%	-13.33%	4.2分
109	恩华药业	-9.55%	-3.31%	4.4分
110	山河药辅	-9.55%	-3.15%	4.2分
111	必贝特	-9.62%	4.68%	5.9分
112	东北制药	-10.07%	-1.41%	4.7分
113	华仁药业	-10.15%	-1.63%	4.5分
114	恒瑞医药	-10.23%	-8.06%	4.9分
115	东诚药业	-10.46%	-1.71%	4.7分
116	同和药业	-10.51%	-3.94%	4.2分
117	神奇制药	-10.53%	-1.06%	5.5分
118	京新药业	-10.54%	-3.60%	4.3分
119	益方生物	-10.56%	-10.72%	4.2分
120	亚虹医药	-11.05%	-2.24%	4.7分
121	华北制药	-11.11%	-5.34%	4.0分
122	华特达因	-11.29%	-3.91%	4.4分
123	联环药业	-11.56%	-4.70%	3.7分
124	海辰药业	-11.81%	-4.81%	4.2分
125	新诺威	-12.06%	-8.84%	4.0分
126	健友股份	-12.24%	-6.26%	4.4分
127	立方制药	-12.29%	-5.95%	4.5分
128	易明医药	-12.45%	-3.56%	5.0分
129	北陆药业	-12.64%	-3.31%	4.4分
130	富祥股份	-13.08%	-5.29%	4.3分
131	ST能特	-13.59%	-4.98%	4.3分
132	北大医药	-14.11%	-6.54%	3.9分
133	苑东生物	-14.52%	-11.98%	4.5分
134	九典制药	-14.53%	-5.83%	4.0分
135	华东医药	-14.62%	-10.22%	4.0分
136	海森药业	-14.85%	-4.91%	4.1分
137	千红制药	-14.88%	-4.39%	4.2分
138	舒泰神	-15.36%	-4.37%	3.7分
139	天宇股份	-15.53%	-4.68%	3.9分
140	中关村	-15.80%	-2.37%	4.9分
141	新和成	-15.92%	-5.58%	4.3分
142	亚太药业	-15.99%	-1.37%	3.9分
143	迪哲医药	-16.56%	-10.94%	4.5分
144	福元医药	-16.79%	-7.49%	4.7分
145	亿帆医药	-16.90%	-6.27%	4.1分
146	誉衡药业	-17.31%	-1.54%	5.1分
147	海南海药	-17.87%	-6.95%	3.8分
148	吉贝尔	-17.99%	-5.58%	4.4分
149	盟科药业	-18.03%	-10.45%	4.2分
150	海翔药业	-18.22%	-5.08%	4.4分
151	金陵药业	-18.31%	-6.22%	4.2分
152	力生制药	-18.82%	-4.70%	4.6分
153	哈药股份	-19.32%	-8.74%	4.3分
154	双鹭药业	-20.61%	-9.51%	4.3分
155	百利天恒	-21.00%	-6.11%	4.1分
156	键凯科技	-22.79%	-8.73%	4.5分
157	奥锐特	-23.99%	-3.74%	5.3分
158	*ST赛隆	-28.14%	-22.65%	3.8分
159	信立泰	-40.07%	-6.49%	4.7分

<上一页 1 2 3 4 5...27 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：5.8基本面打败了48%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，多数机构认为该股长期投资价值较高，投资者可加强关注。

个股深一度

潜在高分红能力：弱（47.5分）

基本面得分最高的股票

[ 截止日期：2026-03-31 ]公司经营

盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 75/219 ， 122/219。

[{"date":"2026-03-31","value":"1.32","vol":"0.43"},{"date":"2025-12-31","value":"4.51","vol":"-2.03"},{"date":"2025-09-30","value":"4.26","vol":"1.53"},{"date":"2025-06-30","value":"2.21","vol":"1.24"},{"date":"2025-03-31","value":"0.96","vol":"-0.13"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净资产收益率(%)	1.32	4.51	4.26	2.21	0.96
行业(%)	0.43	-2.03	1.53	1.24	-0.13

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"27.12","vol":"50.72"},{"date":"2025-12-31","value":"35.04","vol":"49.72"},{"date":"2025-09-30","value":"33.01","vol":"49.60"},{"date":"2025-06-30","value":"32.45","vol":"49.57"},{"date":"2025-03-31","value":"31.42","vol":"49.06"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
销售毛利率(%)	27.12	35.04	33.01	32.45	31.42
行业(%)	50.72	49.72	49.60	49.57	49.06

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 29/219 ， 40/219。

[{"date":"2026-03-31","value":"22.12","vol":"25.51"},{"date":"2025-12-31","value":"9.49","vol":"38.97"},{"date":"2025-09-30","value":"17.67","vol":"141.63"},{"date":"2025-06-30","value":"11.42","vol":"78.56"},{"date":"2025-03-31","value":"5.22","vol":"0.01"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
营业收入同比增长率(%)	22.12	9.49	17.67	11.42	5.22
行业(%)	25.51	38.97	141.63	78.56	0.01

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"46.84","vol":"47.13"},{"date":"2025-12-31","value":"53.02","vol":"-26.11"},{"date":"2025-09-30","value":"51.66","vol":"-2.93"},{"date":"2025-06-30","value":"158.97","vol":"59.61"},{"date":"2025-03-31","value":"51.12","vol":"-10.40"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净利润同比增长率(%)	46.84	53.02	51.66	158.97	51.12
行业(%)	47.13	-26.11	-2.93	59.61	-10.40

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 103/219 ， 124/219。

[{"date":"2026-03-31","value":"0.07","vol":"0.10"},{"date":"2025-12-31","value":"0.32","vol":"0.41"},{"date":"2025-09-30","value":"0.24","vol":"0.31"},{"date":"2025-06-30","value":"0.15","vol":"0.21"},{"date":"2025-03-31","value":"0.06","vol":"0.10"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
总资产周转率(次)	0.07	0.32	0.24	0.15	0.06
行业(次)	0.10	0.41	0.31	0.21	0.10

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.28","vol":"0.65"},{"date":"2025-12-31","value":"1.20","vol":"2.58"},{"date":"2025-09-30","value":"0.89","vol":"1.93"},{"date":"2025-06-30","value":"0.54","vol":"1.29"},{"date":"2025-03-31","value":"0.23","vol":"0.66"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
存货增长率(次)	0.28	1.20	0.89	0.54	0.23
行业(次)	0.65	2.58	1.93	1.29	0.66

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-03-31","value":"-7.75","vol":"-2.81"},{"date":"2025-12-31","value":"32.52","vol":"16.49"},{"date":"2025-09-30","value":"8.84","vol":"4.26"},{"date":"2025-06-30","value":"4.63","vol":"2.95"},{"date":"2025-03-31","value":"-9.22","vol":"-26.33"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
现金流量净额/营业收入	-7.75	32.52	8.84	4.63	-9.22
行业	-2.81	16.49	4.26	2.95	-26.33

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.80","vol":"1.60"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.45","vol":"1.71"},{"date":"2025-03-31","value":"","vol":"0.00"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资本支出／折旧和摊销	-	0.80	-	0.45	-
行业	0.00	1.60	0.00	1.71	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 39/219 ， 26/219。

[{"date":"2026-03-31","value":"1.45","vol":"3.57"},{"date":"2025-12-31","value":"1.44","vol":"3.31"},{"date":"2025-09-30","value":"1.28","vol":"3.48"},{"date":"2025-06-30","value":"1.27","vol":"3.66"},{"date":"2025-03-31","value":"1.21","vol":"3.57"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
流动比率	1.45	1.44	1.28	1.27	1.21
行业	3.57	3.31	3.48	3.66	3.57

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.71","vol":"2.93"},{"date":"2025-12-31","value":"0.84","vol":"2.69"},{"date":"2025-09-30","value":"0.65","vol":"2.73"},{"date":"2025-06-30","value":"0.63","vol":"2.88"},{"date":"2025-03-31","value":"0.58","vol":"2.80"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
速动比率	0.71	0.84	0.65	0.63	0.58
行业	2.93	2.69	2.73	2.88	2.80

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 16/219 ， 38/219。

[{"date":"2026-03-31","value":"45.76","vol":"33.54"},{"date":"2025-12-31","value":"49.49","vol":"34.70"},{"date":"2025-09-30","value":"49.05","vol":"34.06"},{"date":"2025-06-30","value":"49.71","vol":"34.12"},{"date":"2025-03-31","value":"50.05","vol":"34.09"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资产负债率(%)	45.76	49.49	49.05	49.71	50.05
行业(%)	33.54	34.70	34.06	34.12	34.09

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.89","vol":"9.77"},{"date":"2025-12-31","value":"1.03","vol":"1.76"},{"date":"2025-09-30","value":"1.01","vol":"1.19"},{"date":"2025-06-30","value":"1.03","vol":"0.87"},{"date":"2025-03-31","value":"1.05","vol":"1.44"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
产权比率 (%)	0.89	1.03	1.01	1.03	1.05
行业(%)	9.77	1.76	1.19	0.87	1.44

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
中泰证券	2026-03-15	买入	买入

机构预测

机构预测该股2026年每股收益与前一年相同，长期投资价值一般。

[{"date":"2022","yellowRectValue":"3.39","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.12","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.67","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"1.02","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"1.30","blueLineValue":"0.59","type":"YC"}]

[美诺华]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]